NEXLETOL: payments to doctors
Payments that named NEXLETOL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13.3M
- Providers
- 47,520
- Transactions
- 200,518
- Average per transaction
- $66
The per-transaction average — $66 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 47,520 providers the average total is $279, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Esperion Therapeutics, Inc. | $13,197,181 | 99.4% |
| Currax Pharmaceuticals LLC | $73,502 | 0.6% |